|
LOC728640 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76592074296877E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.99515967583375E-12 |
| Normal-vs-Stage2 |
1.02430286474942E-11 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.67976743625786E-13 |
| Stage1-vs-Stage2 |
2.591200E-01 |
| Stage1-vs-Stage3 |
4.151900E-02 |
| Stage1-vs-Stage4 |
8.546200E-02 |
| Stage2-vs-Stage3 |
7.304600E-01 |
| Stage2-vs-Stage4 |
6.746400E-01 |
| Stage3-vs-Stage4 |
9.105600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.39221967287995E-13 |
| Normal-vs-AfricanAmerican |
2.5103999999887E-06 |
| Normal-vs-Asian |
9.71990044007498E-10 |
| Caucasian-vs-AfricanAmerican |
4.681600E-01 |
| Caucasian-vs-Asian |
2.272800E-01 |
| AfricanAmerican-vs-Asian |
8.952600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64102065269844E-12 |
| Normal-vs-Female |
2.0051738047755E-12 |
| Male-vs-Female |
1.451400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.6559201766504E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.77620000321832E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.522400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.462600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.070400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.251900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.088800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.533400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.161240E-01 |
| Classical-VS-Follicular |
4.378200E-01 |
| Classical-VS-Other |
8.580000E-01 |
| Classical-VS-Normal |
8.82482975583798E-12 |
| Tall-VS-Follicular |
2.877600E-01 |
| Tall-VS-Other |
2.829600E-01 |
| Tall-VS-Normal |
1.35425004543777E-12 |
| Follicular-VS-Other |
6.983600E-01 |
| Follicular-VS-Normal |
1.80888637402177E-12 |
| Other-VS-Normal |
3.537300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64468438867971E-12 |
| Normal-vs-N1 |
3.8748000030786E-08 |
| N0-vs-N1 |
5.631600E-02 |
|
|
